# US 2010/0168720 A1 · System for providing fluid flow to nerve tissues

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2010/0168720 A1
- Document ID: US20100168720A1
- Status: Published application
- Kind: A1
- Application number: 12/648,642
- Filed: 2009-12-29
- Published: 2010-07-01
- Earliest claimed: 2008-12-31
- Assignees: KCI Licensing, Inc.
- Inventors: Larry D. Swain; Michael E. Manwaring; Douglas A. Cornet; Braden K. Leung
- Web page: https://patentgrep.com/patent/US20100168720A1

## CPC

- A61B 17/11: for performing anastomosis; Buttons for anastomosis
- A61B 17/1128: {of nerves}
- A61F 13/00063: {comprising medicaments or additives, e.g. odor control, PH control, debriding, antimicrobic (drug delivery dressings A61K9/70; chemical aspect of the additives A61L15/00)}
- A61F 13/05: specially adapted for use with sub-pressure or over-pressure therapy, wound drainage or wound irrigation, e.g. for use with negative-pressure wound therapy [NPWT]
- A61M 1/915: {Constructional details of the pressure distribution manifold}
- A61M 1/92: {with liquid supply means}
- A61P 17/02: for treating wounds, ulcers, burns, scars, keloids, or the like
- A61P 25/00: Drugs for disorders of the nervous system
- A61M 1/94: {with gas supply means}
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

Provided is an apparatus that includes a nerve conduit and a nested manifold for providing a reduced pressure. Also provided is a system that includes a source of reduced pressure, a nerve conduit and nested manifold, and a conduit for providing fluid communication between the manifold and the source of reduced pressure. Additionally provided is a method that includes implanting the above nerve conduit and manifold at a site of damaged nerve tissue and applying a reduced pressure to the manifold thereby stimulating repair or regrowth of nerve tissue.

## Claims

### Claim at position 1

-29. (canceled)

### Claim 30

A system for providing reduced pressure to a defect at a tissue site of a nerve, the apparatus comprising:
a pressure source for supplying the reduced pressure;
a nerve conduit having a generally tubular shape and having a luminal wall for surrounding the tissue site to contain fluids within a luminal space between the tissue site and the luminal wall;
a manifold fluidly coupled to the pressure source to distribute the reduced pressure to the defect; and
a scaffold comprising at least one scaffold guide having a generally frusto-tubular shape with a base opening at one end and a vertex opening at the other end wherein the at least one scaffold guide is positioned within the luminal space in fluid communication with the manifold and oriented therein with the vertex opening positioned closer to the manifold than the base opening;
whereby the at least one scaffold guide facilitates tissue growth at the tissue site by organizing matrix deposition, promoting cell binding, or guiding the migration of cells through the luminal space.

### Claim at position 3

-58. (canceled)

### Claim 59

A method for providing reduced pressure to a defect at a tissue site of a nerve, the method comprising:
implanting a nerve conduit having a generally tubular shape and having a luminal wall for surrounding the tissue site to contain fluids within a luminal space between the tissue site and the luminal wall;
implanting a manifold for receiving reduced pressure and in fluid communication with the luminal space to distribute the reduced pressure to the defect;
implanting a scaffold comprising at least one scaffold guide having a generally frusto-tubular shape with a base opening at one end and a vertex opening at the other end wherein the at least one scaffold guide is positioned within the luminal space in fluid communication with the manifold and oriented therein with the vertex opening positioned closer to the manifold than the base opening;
sealing the nerve conduit around the tissue site to contain fluids within the luminal space; and
applying reduced pressure through the manifold to the tissue site.

### Claim 60

(canceled)

### Claim 61

An apparatus for providing reduced pressure to a defect at a tissue site of a nerve, the apparatus comprising:
a nerve conduit having a luminal wall for surrounding the tissue site and forming a luminal space between the tissue site and the luminal wall;
a manifold having a connector for receiving reduced pressure to distribute the reduced pressure to the defect; and
a scaffold having a generally tubular frustum shape extending between a base opening at one end and a vertex opening at the other end, the scaffold being positioned within the luminal space with the vertex opening oriented closer to the manifold.

### Claim 62 (depends on 61)

The apparatus of claim 61, wherein the defect is a severed nerve.

### Claim 63 (depends on 61)

The apparatus of claim 61, wherein the defect is a pinched, partially severed, or degenerative nerve extending through the vertex opening of the scaffold.

### Claim 64 (depends on 61)

The apparatus of claim 61, wherein the scaffold is substantially non-porous.

### Claim 65 (depends on 61)

The apparatus of claim 61, wherein the scaffold comprises pores that are sufficiently small to bind cells and proteins.

### Claim 66 (depends on 61)

The apparatus of claim 61, wherein the scaffold is composed of a hydrophobic or a hydrophilic material.

### Claim 67 (depends on 61)

The apparatus of claim 61, wherein the scaffold further comprises at least one fiber guide extending through the luminal space and the vertex opening of the scaffold.

### Claim 68 (depends on 67)

The apparatus of claim 67, wherein the at least one fiber guide is in fluid communication with the tissue site of the nerve.

### Claim 69 (depends on 67)

The apparatus of claim 67, wherein the at least one fiber guide is in fluid communication with the manifold and the scaffold.

### Claim 70 (depends on 67)

The apparatus of claim 67, wherein the at least one fiber guide comprises fibrous protrusions extending into the luminal space.

### Claim 71 (depends on 67)

The apparatus of claim 67, wherein the at least one fiber guide is generally linear.

### Claim 72 (depends on 67)

The apparatus of claim 67, wherein the at least one fiber guide is bioabsorbable.

### Claim 73 (depends on 72)

The apparatus of claim 72, wherein the at least one fiber guide is comprised of collagen or fibrin.

### Claim 74 (depends on 61)

The apparatus of claim 61, wherein the manifold is positioned adjacent the distal side of the nerve.

### Claim 75 (depends on 61)

The apparatus of claim 61, wherein the manifold provides reduced pressure preferentially to the distal side of the nerve.

### Claim 76 (depends on 61)

The apparatus of claim 61, wherein the manifold is composed of a bioinert or bioabsorbable material.

### Claim 77 (depends on 61)

The apparatus of claim 61, wherein the manifold is substantially tubular or cylindrical in shape and positioned within the luminal space.

### Claim 78 (depends on 61)

The apparatus of claim 61, wherein the manifold extends through the wall of the nerve conduit in fluid communication with the luminal space.

### Claim 79 (depends on 61)

The apparatus of claim 61, wherein the scaffold is formed from a foam or gel material.

### Claim 80 (depends on 61)

The apparatus of claim 61, wherein the scaffold comprises a bioactive agent.

### Claim 81 (depends on 80)

The apparatus of claim 80, wherein the bioactive agent is at least one of an antibiotic, an antibody and a growth factor.

### Claim 82 (depends on 80)

The apparatus of claim 80, wherein the bioactive agent is a growth hormone (GH), a bone morphogenetic protein (BMP), transforming growth factor-α (TGF-α), a TGF-β, a fibroblast growth factor (FGF), granulocyte-colony stimulating factor (G-CSF), granulocyte/macrophage-colony stimulating factor (GM-CSF), epidermal growth factor (EGF), platelet derived growth factor (PDGF), insulin-like growth factor (IGF), vascular endothelial growth factor (VEGF), hepatocyte growth factor/scatter factor (HGF/SF), an interleukin, tumor necrosis factor-α (TNF-α) or nerve growth factor (NGF).

### Claim 83 (depends on 61)

The apparatus of claim 61, wherein the nerve conduit comprises a slice along its length that forms an opening whereby the nerve conduit is implantable around the tissue site and sealable with one or more closure elements.

### Claim 84 (depends on 61)

The apparatus of claim 61, wherein the nerve conduit is composed of a bioinert material.

### Claim 85 (depends on 61)

The apparatus of claim 61, wherein the nerve conduit is composed of a bioabsorbable material.

### Claim 86 (depends on 85)

The apparatus of claim 85, wherein the nerve conduit is composed of collagen.

### Claim 87 (depends on 61)

The apparatus of claim 61, wherein the nerve conduit comprises pores.

### Claim 88 (depends on 87)

The apparatus of claim 87, wherein the pores are sufficiently small to exclude the entry of cells from tissue surrounding the nerve conduit into the luminal space.

### Claim 89 (depends on 88)

The apparatus of claim 88, wherein the pores have a diameter of between about 5 μm and about 50 μm.

### Claim 90 (depends on 61)

The apparatus of claim 61, wherein the manifold is in fluid communication with the scaffold.
